carb counting with lenny Mean plasma glucose A1C (%)mg/dLmmol/L 61267.0 71548.6 818310.2 921211.8 1024013.4 1126914.9 1229816.5 Correlation of.

Slides:

Advertisements

Similar presentations

1 Prediabetes Comorbidities and Complications. 2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep.

Advertisements

Diagnosis of Type 2 Diabetes 1. Glucose Testing and Interpretation: AACE Diagnostic Criteria TestResultDiagnosis FPG, mg/dL (measured after 8-hour fast)

Diabetes in Pregnancy Screening.

Diagnosis of Type 2 Diabetes 1. Diagnostic Criteria for Prediabetes and Diabetes in Nonpregnant Adults 2 NormalHigh Risk for DiabetesDiabetes FPG

Screening for Diabetes in Pregnancy 1. Gestational Diabetes Mellitus Screening GDM, gestational diabetes mellitus. Handelsman YH, et al. Endocr Pract.

Provided Courtesy of Nutrition411.com Where Health Care Professionals Go for Information Carbs Are the Key: Current Nutrition for Diabetes Review Date.

Diabetes Mellitus Ibrahim Sales, Pharm.D. Assistant Professor of Clinical Pharmacy King Saud University

Type 2 Diabetes- Treatment Toolbox by: Karen L. Staples, FNP, ACNP Where Do I Start?

LDL Program Medical Management Philip E. Johnston, Pharm.D.

Consider testing if person is: – Overweight or obese with additional risk factor for diabetes – Age 45 or older Obtain: A1C or FPG or 2-hour plasma glucose.

Cost-Effectiveness of Treatment Strategies for Comorbid Diabetes and Dyslipidemia Part 3.

Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.

DIABETES Use of the Estimated Average Glucose (eAG) in Patient Care Part 2 of 2.

Diabetes Mellitus 101 for Medical Professionals An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes: Stan Schwartz MD,FACP.

Diabetes Update Division of Endocrinology Department of Medicine Wayne State University Medical School Detroit, Michigan Part 1 of 3.

Therapy of Type 2 Diabetes Mellitus: UPDATE

© American Medical Association. All rights reserved. Modifications to any data or analysis provided requires either AMA written permission or the.

An Educational Service from GlycoMark

 SC Guidelines for Diabetes Care Screening for Diagnosis of Diabetes To test for diabetes or to assess risk of future diabetes, either A1C, Fasting.

Use of EHR & Quality Based on Zhou, et al. The Relationship between Electronic Health Record Use and Quality of Care over Time. J Am Med Inform Assoc.

Achieving Glycemic Control in the Hospital Setting

Treatment Guidelines and Disease State Management Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2015.

Improving Patient Outcomes in Diabetes Matt Petersen Managing Director, Medical Information & Professional Engagement American Diabetes Association.

Achieving Optimal Glycaemic Control: Can Insulin Deliver?

Prediabetes: Targeting a population at risk

James Thrasher, MD The American Journal of Medicine

Screening for Diabetes in Pregnancy

Copyright © 2015 by the American Osteopathic Association.

Source: Reprinted with permission from the American Association of Clinical Endocrinologists. Garber AJ, Abraham-son, MJ, Barzilay JI, et al. AACE comprehensive.

Copyright © 2017 American Academy of Pediatrics.

W.S.T. Swarnasri1, Noel P. Somasundaram2

Patient Case Discussions in T2D: What Intensification Plan Is Best?

Screening for Diabetes in Pregnancy

Current Therapy for Type II Diabetes

Options for Combination Therapy in Type 2 Diabetes: Comparison of the ADA/EASD Position Statement and AACE/ACE Algorithm Timothy Bailey, MD The American.

James Thrasher, MD The American Journal of Medicine

Distribution of the absolute percentage differences of each basal rate estimate to final basal rates. Distribution of the absolute percentage differences.

Disease Progression in Type 2 Diabetes

Protocol for the management of adult patients with HHS

The means and SDs of the data from all Glucommander runs from 1984 to 1998 are graphed. The means and SDs of the data from all Glucommander runs from 1984.

Predicted and observed HbA1c levels using doubly robust estimation adjusting for either a comprehensive set of confounders (left panel) or a set of confounders.

Relationship between self-reported adherence to USPSTF/ADA guidelines and evidence from EMR.† The concordance analysis was performed on only 281 surveyed.

Distribution of the percentage differences of each basal rate estimate to final basal insulin rates. Distribution of the percentage differences of each.

Patient flow chart: the final prospective study population consisted of 521 individuals, 113 on basal insulin and 408 on OADs. *Plausibility: height (130–230 cm),

Mean daily glucose concentration and frequency of hypoglycemia in long-term care residents with type 2 diabetes. Mean daily glucose concentration and frequency.

Predicted and observed BMI levels using doubly robust estimation adjusting for either a comprehensive set of confounders (left panel) or a set of confounders.

Part 3 This slide reviews recommendations for the frequency of A1C testing from the 2015 ADA guidelines. Refer to source document for full recommendations,

Range of mean changes from baseline in A1C in clinical studies of 24–52 weeks’ duration reported in prescribing information for five GLP-1 receptor agonists.

Assessing Diabetes Care at the Cornell Scott-Hill Health Center

Medical Care In Diabetes

When queried about the supply of endocrinologists to manage diabetes, respondents felt that there are not enough endocrinologists. When queried about the.

Serial measurements of serum glucose, anion gap, serum carbon dioxide, and serum triglycerides throughout the patient's hospital stay. Serial measurements.

Percentage of patients with type 2 diabetes with A1C < 7% (n = 248), blood pressure > 130/80 mmHg (n = 248), and LDL cholesterol < 100 mg/dl (n = 207)

Plasma levels of GLP-1 are increased in patients with critical illness and correlate with disease severity. Plasma levels of GLP-1 are increased in patients.

Observed RW, modeled, and published trial estimates of HbA1c change from baseline. Observed RW, modeled, and published trial estimates of HbA1c change.

Glucose stimulates GLP-1 secretion from the perfused rat intestine by a dose- and absorption-dependent manner. Glucose stimulates GLP-1 secretion from.

Estimated glucose delta values (mmol/L) after glucagon injection (5 µg/kg) in octreotide-treated rats. Estimated glucose delta values (mmol/L) after glucagon.

Comparison of the percentages of ducts in the pancreas containing cells showing positive staining for the different markers between control patients and.

Comorbid conditions and concomitant medications.

Effects of vinegar (□) and placebo (⧫) on plasma glucose (A–C) and insulin (D–F) responses after a standard meal in control subjects, insulin-resistant.

Clinical responses to therapy from baseline to week 24 and end point with last observation carried forward (LOCF). Clinical responses to therapy from baseline.

Incidence of DM as a function of TyG index (white bars) or TG/HDL-C ratio (black bars). Incidence of DM as a function of TyG index (white bars) or TG/HDL-C.

Plots of average estimated and measured GFR vs

Doses of trial medication in the liraglutide groups (A) and in the placebo groups (B). Doses of trial medication in the liraglutide groups (A) and in the.

A1C at baseline, 16 weeks, and 32 weeks according to study group in all participants (A), adult participants (B), and adolescent participants (C) who returned.

Cumulative distributions of A1C and fasting plasma glucose values for the U.S. population aged ≥12 years without diabetes for each survey cycle: 1999–2000,

Four–time point diurnal profiles of plasma glucose concentrations (A) and AUCs (B) over quintiles of HbA1c. ○, AUC1; •, AUC2; ▴, AUC2 − AUC1 (differences.

Changes of major clinical and biochemical characteristics at baseline and during follow-up in different groups. Changes of major clinical and biochemical.

Cumulative mean numbers of confirmed (plasma glucose ≤3

Presentation transcript:

carb counting with lenny

Mean plasma glucose A1C (%)mg/dLmmol/L Correlation of A1C with Average Glucose ADA. V. Diabetes Care. Diabetes Care 2014;37(suppl 1):S23; Table 8 These estimates are based on ADAG data of ~2,700 glucose measurements over 3 months per A1C measurement in 507 adults with type 1, type 2, and no diabetes. The correlation between A1C and average glucose was A calculator for converting A1C results into estimated average glucose (eAG), in either mg/dL or mmol/L, is available at

Final thoughts – JOB SECURITY--- Develop a passion for DIABETES : 2050 is coming!! – LOOK for Pre-Diabetes – Treat within the guidelines – Match the patient with the meds – THINK like a pancreas – “Ya Gotta “ have NUMBERS at EVERY visit – NO HYPO!!!!!! – BE a COLUMBO ---- Investigate!! – Change YOUR behavior first!! Try out the carb books, apps, whatever it takes!!! – Don’t hesitate to contact me for assistance!!!!

References 1. Garber AJ, Abrahamson MJ, Barzilay JI, et al. American Association of Clinical Endocrinologists’ comprehensive diabetes management algorithm 2013 consensus statement. Endocr Prac. 2013; 19(supple 2): American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2014; 37(suppl 1): S14-S80 3. PL Detail-Document, Comparison of GLP-1 Agonists. Pharmacist’s Letter/Prescriber’s Letter. August PL Detail-Document, Drugs for Type 2 Diabetes. Pharmacist’s Letter/Prescriber’s Letter. August 2013.

Karen L. Staples, FNP, ACNP Currently practicing in Endocrine focus and Diabetes Management McLeod Physician’s Associates- Southern Medical Associates (SMA) 3418 Casey Street Loris, SC (843)